Coadministration of 3′5-dimaleamylbenzoic acid and quercetin decrease pulmonary fibrosis in a systemic sclerosis model
Edilburga Reyes-Jiménez, Alma Aurora Ramírez-Hernández, Jovito Cesar Santos-Álvarez, Juan Manuel Velázquez-Enríquez, Karina González-García, Gabriela Torres, Saúl Villa‐Treviño, Rafael Baltiérrez‐Hoyos, Verónica Rocío Vásquez-Garzón
Topics & Concepts
BleomycinPulmonary fibrosisFibrosisMedicineMasson's trichrome stainPathologyIdiopathic pulmonary fibrosisProinflammatory cytokineOxidative stressInternal medicineLungInflammationChemotherapySystemic Sclerosis and Related DiseasesInterstitial Lung Diseases and Idiopathic Pulmonary FibrosisPulmonary Hypertension Research and Treatments